Diabetic specific aspects in antithrombotic therapy in patients with coronary artery disease.
Farhan
S
S
Department of Medicine, Cardiology and Emergency Medicine, Wilhelminen Hospital, Vienna, Austria. serdar.farhan@wienkav.at
Höchtl
T
T
Wojta
J
J
Huber
K
K
D001777:Blood Coagulation / Q000502:physiology; D001792:Blood Platelets / Q000502:physiology; D003324:Coronary Artery Disease / Q000097:blood / Q000188:drug therapy*; D003920:Diabetes Mellitus / Q000097:blood*; D003925:Diabetic Angiopathies / Q000097:blood / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors